MELD Exception Points: When Your Score Doesn't Tell the Whole Story

Last updated: March 2026 · 13 min read · Medically reviewed content

If you or a loved one is on the liver transplant waiting list, you know that your MELD score determines your priority — the higher the score, the sooner you're likely to receive an organ offer. But what happens when your MELD score doesn't reflect how sick you actually are?

This is exactly the problem that MELD exception points were created to solve. There are conditions — most notably hepatocellular carcinoma (liver cancer) — where your lab-based MELD score may be low, but your risk of death or disease progression without transplant is high. Exception points bridge that gap, giving you a score that more accurately reflects your true urgency.

This guide explains what MELD exception points are, who qualifies, how the system works (including the current MMaT-3 formula), what conditions are eligible, and what you should discuss with your transplant team.

⚡ Know Your Current MELD Score

Use our free MELD & Clinical Score Calculator to calculate your MELD, MELD-Na, and MELD 3.0 scores instantly. For ongoing tracking, upload your labs to LiverTracker — your scores are recalculated automatically with each upload.

Why Exception Points Exist

The MELD score is calculated from three lab values: bilirubin, INR, and creatinine (plus sodium in MELD-Na). It was designed to predict 90-day mortality risk from liver failure. The higher your MELD, the sicker your liver, and the higher your transplant priority.

But there's a fundamental problem: not all life-threatening liver conditions cause lab values to deteriorate. The clearest example is liver cancer (HCC). A patient with a small tumor inside a cirrhotic liver may have relatively well-preserved liver function — their bilirubin, INR, and creatinine might be near normal, giving them a low MELD score (say, 10–15). But without transplant, that tumor will grow, potentially spread, and eventually kill them.

If transplant allocation relied only on lab-based MELD, these patients would wait indefinitely while their cancer progressed beyond the point where transplant could help. Exception points solve this by assigning an adjusted MELD score that reflects the patient's true mortality risk — not just their liver function.

How Exception Points Work: The MMaT-3 System

The current system for awarding MELD exception points is based on the MMaT-3 formula (Median MELD at Transplant minus 3). Here's how it works:

Step by Step

1. Your transplant center calculates the Median MELD at Transplant (MMaT) for your geographic area — this is the median MELD score at which patients actually receive transplant offers within a 250-nautical-mile radius of your center. This number is recalculated every 6 months by UNOS using the prior 12 months of data.

2. Your exception score = MMaT minus 3. For example, if the MMaT in your area is 31, your exception score would be 28.

3. You are listed at either your lab-based MELD or your exception score — whichever is higher.

Why "Minus 3"?

The MMaT-3 formula was implemented to balance access between patients with HCC (who receive exception points) and patients without HCC (whose MELD reflects only liver function). Before this system, HCC patients were often transplanted very quickly — sometimes ahead of sicker patients — because their exception scores were set too high. The minus-3 adjustment ensures that exception patients are prioritized appropriately without leapfrogging patients with severe liver failure.

Important: The Exception Score Does Not Increase Over Time

Under the current policy, your exception score is fixed at MMaT-3. It does not automatically increase every few months as it did under the old system. This was a deliberate change to prevent over-prioritization of HCC patients.

Who Qualifies for Exception Points?

MELD exception points fall into two categories:

1. Standardized Exceptions (Automatic If Criteria Are Met)

These are conditions for which UNOS policy provides clear criteria. If your transplant team documents that you meet these criteria, exception points are approved through a streamlined process reviewed by the National Liver Review Board (NLRB).

2. Non-Standardized Exceptions (Case-by-Case Review)

For conditions not listed above but where your transplant team believes your MELD doesn't reflect your true mortality risk, they can submit a narrative exception request to the NLRB. Common conditions that may qualify include cholangiocarcinoma (hilar), intractable pruritus from cholestatic diseases, refractory ascites with recurrent infections, recurrent cholangitis in PSC, small-for-size syndrome after living donor transplant, hepatic epithelioid hemangioendothelioma, neuroendocrine tumors metastatic to the liver, and colorectal liver metastases (under specific protocols).

These requests are reviewed by a panel of transplant physicians and surgeons from across the country. Approval is not guaranteed and requires strong documentation from your transplant team.

HCC Exception Points: The Most Common Scenario

Liver cancer (HCC) is by far the most common reason for MELD exception points — roughly 15% of all transplant candidates receive an HCC exception. Here's how it works in detail:

Eligibility (Milan Criteria)

To qualify for standardized HCC exception points, you must have a tumor (or tumors) within the Milan criteria:

• Single tumor ≤5 cm in diameter, OR

• Up to 3 tumors, each ≤3 cm

• No vascular invasion (tumor hasn't invaded blood vessels)

• No extrahepatic spread (cancer hasn't spread beyond the liver)

• AFP ≤1,000 ng/mL

• Not eligible for surgical resection

These criteria were established by Dr. Vincenzo Mazzaferro in a landmark 1996 study showing that transplant patients within these limits had excellent outcomes — 5-year survival rates of approximately 70–80%.

The 6-Month Mandatory Waiting Period

Before you receive exception points, there is a mandatory 6-month observation period after your HCC is identified and you're listed for transplant. During this period, you're listed at your actual lab-based MELD score (which may be quite low). The purpose of this waiting period is to observe tumor behavior (aggressive tumors that grow rapidly despite treatment may not benefit from transplant), allow time for locoregional therapy (ablation, TACE) to control the tumor, and reduce geographic variability in transplant timing.

After 6 Months

If your tumor remains within Milan criteria after the 6-month waiting period, your transplant center requests exception points from the NLRB. If approved, your MELD is set to MMaT-3 for your area. You are then listed at this higher score, which significantly improves your position on the waiting list.

What About Downstaging?

If your tumor initially exceeds Milan criteria, you may still qualify through a process called downstaging — using locoregional therapy (TACE, ablation, radiation) to shrink the tumor into Milan criteria. Under current UNOS policy, specific downstaging criteria exist, and if your tumor successfully meets Milan criteria after treatment and remains stable for an additional observation period, you can receive exception points. AFP must also be below 500 ng/mL after treatment.

The National Liver Review Board (NLRB)

Before 2019, exception requests were reviewed by Regional Review Boards — each of the 11 UNOS regions had its own board with its own criteria. This led to wide variability: approval rates ranged from 75.8% to 93.5% depending on where you lived.

In May 2019, UNOS replaced the regional boards with the National Liver Review Board (NLRB), a nationwide peer review system that provides consistent, standardized review of all exception requests. The NLRB has three specialty boards: one for HCC exceptions, one for non-HCC adult exceptions, and one for pediatric exceptions.

Reviewers are transplant physicians and surgeons from across the country, assigned to ensure no geographic bias. This system has significantly reduced regional variation in exception approvals and created a more equitable process for all transplant candidates.

Status 1A and 1B: Beyond Exception Points

There are two special categories that bypass the MELD system entirely because they represent the most urgent situations:

Fewer than 1% of all liver transplant candidates are in Status 1A or 1B at any given time. These patients receive organ offers before anyone on the MELD-based waiting list.

What This Means for You

If You Have HCC

• Make sure your transplant team is aware of your tumor and has documented it with proper LI-RADS imaging

• Understand that you'll be listed at your lab-based MELD for the first 6 months — this is normal and required by policy

• Ask about locoregional therapy (TACE, ablation) to control your tumor during the waiting period

• After 6 months, your team will request exception points — ask what the current MMaT is for your area and what your exception score would be

• Track your AFP level at every lab draw — rising AFP can affect your exception eligibility (must stay ≤1,000 for initial exception; ≤500 after downstaging). Upload labs to the report tracker and watch your AFP on trend charts.

If You Have a Non-HCC Condition

• Discuss with your transplant team whether an exception request is appropriate for your situation

• Conditions like refractory ascites, hepatopulmonary syndrome, recurrent cholangitis, and intractable pruritus may qualify

• Your team will need to write a detailed narrative justification to the NLRB — having complete lab trend data and imaging history strengthens the case. Share your LiverTracker record with your transplant coordinator.

If Your MELD Seems "Too Low" for How You Feel

• Talk to your transplant team. The MELD score doesn't capture everything — fatigue, quality of life, nutritional status, and certain complications like encephalopathy and recurrent infections aren't reflected in the formula.

• Your team can advocate for you through the exception process if they believe your MELD doesn't reflect your true risk

• Tracking your lab trends over time helps build the case — a steadily worsening trajectory, even with a "moderate" current MELD, is meaningful data for exception requests

The Future: Expanding Exception Criteria

The transplant community is actively debating whether the criteria for HCC exception points should be expanded beyond the original 1996 Milan criteria. A 2025 analysis in Transplantation reviewed nearly 30 proposed criteria sets and found that less-restrictive criteria (such as UCSF, Up-to-Seven, and Metroticket 2.0) result in similar post-transplant survival while allowing more patients access to transplant.

Additionally, the 2025 OPTN guidance expanded exception consideration to include intrahepatic cholangiocarcinoma (iCCA), neuroendocrine tumors (NET), and colorectal liver metastases (CRLM) under specific protocols — reflecting the growing field of "transplant oncology" that is broadening which cancers are treatable by transplant.

These developments mean that if you have a liver cancer that doesn't fit the traditional HCC criteria, it's worth discussing the latest policies with your transplant team — the landscape is evolving rapidly.

Frequently Asked Questions

What are MELD exception points?

Exception points are an adjustment to your lab-based MELD score that gives you a higher score on the transplant waiting list. They're awarded when your MELD doesn't reflect your true mortality risk — most commonly because you have liver cancer (HCC) with relatively preserved liver function. Your adjusted score is set at MMaT-3 (the median MELD at transplant in your area, minus 3).

How long do I have to wait before getting exception points for HCC?

There is a mandatory 6-month waiting period after your HCC is identified and you're listed for transplant. During this time, you're listed at your actual lab-based MELD. After 6 months, if your tumor remains within Milan criteria, your transplant team requests exception points from the NLRB.

Do my exception points increase over time?

No — not under the current policy. Your exception score is fixed at MMaT-3. The old system awarded incremental increases every 3 months, but this was discontinued because it over-prioritized HCC patients relative to non-HCC patients. However, the MMaT itself is recalculated every 6 months based on transplant activity in your area, so your exception score may shift slightly with each recalculation.

What happens if my tumor grows beyond Milan criteria while I'm waiting?

If your tumor exceeds Milan criteria, you may lose your standardized exception points. However, your transplant team can pursue downstaging (using locoregional therapy to shrink the tumor back within criteria) or request a non-standardized exception from the NLRB with a narrative justification. This is a critical situation — stay in close contact with your transplant team and keep all imaging appointments.

Can I get exception points for conditions other than cancer?

Yes. Hepatopulmonary syndrome, portopulmonary hypertension, familial amyloid polyneuropathy, cystic fibrosis, and primary hyperoxaluria all have standardized exception pathways. For other conditions (refractory ascites, recurrent cholangitis, intractable pruritus, etc.), your team can request a non-standardized exception through the NLRB on a case-by-case basis.

How does tracking my labs help with exception points?

For HCC patients, tracking your AFP trend is critical — your AFP must stay below specific thresholds to maintain eligibility. For non-HCC exception requests, a documented history of worsening labs despite treatment strengthens your team's case to the NLRB. Upload every lab report to the report tracker and monitor trends with trend tracking. Share your complete record with your transplant coordinator so they have the data they need.

Medical References & Sources

1. AASLD. Why do we use the MELD score? Part 2. 2021. AASLD

2. OPTN. Guidance to Liver Transplant Programs and the NLRB: Adult Transplant Oncology. February 2025. OPTN PDF

3. PMC. Standardizing MELD Exceptions: Current Challenges and Future Directions. PMC Full Text

4. World J Gastroenterol. Liver transplant allocation policies and outcomes in United States. 2022. WJG Full Text

5. UNOS. Updated liver allocation policy regarding HCC criteria. July 2023. UNOS

6. Transplantation. Time to Expand Selection Criteria for MELD Exception Points. 2025. LWW Full Text

Related Articles & Tools on LiverTracker

• What Is MELD Score? A Patient-Friendly Guide

• Understanding the Liver Transplant Waiting List

• Child-Pugh Score Explained

• Cirrhosis Stages Explained

• Living with Ascites

• Portal Hypertension and Varices

• Complete Guide to Liver Function Tests

• MELD Score Calculator

• Liver Enzyme Checker

• Browse All Articles

🎯 Know Your Score — Track Your Priority

Whether you're waiting for exception points or tracking your lab-based MELD, every data point matters. Upload your labs, watch your trends, and share with your transplant team.

→ Calculate Your MELD Score

→ Create Your Free Account

→ Download the iOS App

Medical Disclaimer: This article is for informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. MELD exception policies change periodically — always discuss your specific situation with your transplant team for the most current information. LiverTracker does not provide medical advice. For our complete disclaimer, visit livertracker.com/medical-disclaimer.